Journal of Substance Abuse Treatment
Volume 38, Issue 4 , Pages 338-345, June 2010

High rates of sustained virological response in hepatitis C virus-infected injection drug users receiving directly observed therapy with peginterferon alpha-2a (40KD) (PEGASYS) and once-daily ribavirin

  • Michael Waizmann, M.D.

      Affiliations

    • Corresponding Author InformationCorresponding author. MEDCENTER Leipzig, Karl-Tauchnitz-Str. 3, DE-04107 Leipzig, Germany. Tel.: +49 3 41 1 49 76 96; fax: +49 3 41 1 49 76 97.
    • ,
  • Grit Ackermann, M.D.

MEDCENTER Leipzig, Karl-Tauchnitz-Str. 3, DE-04107 Leipzig, Germany

Received 1 October 2009; received in revised form 3 February 2010; accepted 8 February 2010. published online 02 April 2010.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0740-5472(10)00029-2

doi:10.1016/j.jsat.2010.02.002

Journal of Substance Abuse Treatment
Volume 38, Issue 4 , Pages 338-345, June 2010

Article Tools

* Image Usage & Resolution